Fertility Education

Understanding Genetic Testing and Screening for Sperm Donors

Reputable sperm banks require all donors to undergo extensive genetic testing and genetic counseling before being accepted into a program.

Book a Free Consultation Browse Donors

Extended Carrier Screening

Everyone carries genetic mutations. Because individuals typically inherit two copies of each gene, carrying a single mutation usually leaves a person perfectly healthy. However, if two carriers of the same mutated gene conceive a child, there is a 25% chance the child will inherit the mutation from both parents and develop the associated genetic condition.

To mitigate this risk, donors undergo extended carrier screening for approximately 500 common and rare gene mutations. This allows intended parents to compare a donor’s screening results with their own, confirming they do not share the same genetic mutations.

Typical Donor Screening Workflow

Chromosome Analysis (Karyotype)

A karyotype is essentially a photograph of a person's chromosomes arranged by size. This standard test ensures that the donor has the correct number and structural configuration of chromosomes, which for men is 46, XY.

Expert Genetic Counseling

Every donor candidate meets with a genetic counselor to carefully review their carrier screening, karyotype, and a detailed personal and family health history. Genetic counselors construct a comprehensive 3- to 4-generation family medical pedigree, mapping out the health history of the donor's parents, grandparents, siblings, aunts, uncles, and cousins. This extensive familial mapping is essential because it helps counselors identify clinical patterns of inheritance for complex or multifactorial conditions that standard DNA carrier screening panels cannot detect.

Genetic counselors evaluate candidates based on strict guidelines established by the American Society for Reproductive Medicine and the American Board of Genetic Counselors:

Disqualifying Conditions: Candidates are typically disqualified if there is a personal or family history of severe mental illness, intellectual disability, congenital malformations, or gene mutations that cause significant symptoms.
Common Medical Conditions: Many common issues—such as hypertension, thyroid disorders, or asthma—are multifactorial, meaning they are caused by a mix of genetics and environment. These do not automatically exclude a donor unless the condition occurs unusually often in the family, begins at a very young age, or poses a high genetic risk to offspring.
Cancer History: Counselors also review the donor's family history of cancer to determine if specific cancer gene screening is warranted, based on National Comprehensive Cancer Network (NCCN) criteria.

Requests for Additional Testing

Patients occasionally desire testing beyond a bank's standard carrier screening panel, either for general peace of mind or because they are known carriers of a specific gene mutation. Whenever possible, most sperm banks will work with patients to test the donor for significant mutations not on their panel, provided the donor consents to the extra screening.

Understanding Testing Limitations

There are specific scenarios where additional testing is generally not approved. These industry-standard policies are in place to protect both the integrity of the donor pool and the wellbeing of the donor:

Common or Adult-Onset Markers: Tests for highly common genes that rarely cause illness (like HFE or MTHFR) or variable adult-onset markers (like ApoE or cholesterol markers) are usually not included in carrier panels. Testing positive for these rarely guarantees the condition will manifest. Over-testing for these genes causes unwarranted anxiety and leads to the unnecessary disqualification of healthy donors.
Unindicated Cancer Screening: If a genetic counselor determines a donor does not meet the clinical criteria for cancer screening, sperm banks typically will not perform the test. This respects the donor’s "right not to know" their risk for adult-onset diseases, especially when no clinical indication exists. Testing without a clinical reason can uncover Variants of Unknown Significance (VUS) - vague results that provide no clear medical action plan but carry heavy emotional distress and potential insurance implications for the donor.

Handling Adverse Genetic Events (Post-Pregnancy Reporting)

Even with extensive screening protocols, genetic disease can sometimes occur. Reputable sperm banks maintain strict bio-vigilance systems to manage these reports. Upon receiving a report of a potential adverse reaction, banks rapidly triage the case to Clinical Geneticists and Medical Directors and place the implicated donor vials under temporary quarantine. If a significant risk is confirmed, the bank initiates a look-back process to formally notify the treating clinics and recipients who received the implicated vials. Depending on the severity of the findings, the donor may be permanently blocked from new distributions or placed on a restricted status that requires specific informed consent from patients prior to any future use.

Keep Reading

Related Guides

Browse the Education Center

Donor Choice